Compare cancer staging systems to guide treatment choices
Part of Cancer, Ear, nose & throat, Mouth & dental clinical trials.
This study tests whether using a newer way to stage nasopharyngeal cancer helps doctors choose the best chemotherapy and radiation plan. It may improve treatment selection by matching therapy intensity and timing to your cancer stage.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have nasopharyngeal carcinoma confirmed by pathology (biopsy/surgery results).
- You have not been treated for this cancer before.
- Your cancer stage is not the earliest stage (not T1N0M0 using the 7th edition system).
- You are between 18 and 64 years old.
- You are well enough to do daily activities (Karnofsky score 70 or higher).
- You can take part in visits and follow-up, can communicate, and can consent willingly.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is for people with high-risk, newly diagnosed stage T3N1M0 nasopharyngeal cancer. It compares whether you need chemotherapy first (before radiation and chemotherapy together) to improve outcomes.
This trial compares two approaches for people with early-stage nasopharyngeal cancer that can be removed with surgery. It tests whether giving less intense chemotherapy and radiation after surgery works as well as a standard dose, with fewer side effects.
This trial compares two different chemotherapy combinations given before radiation for nasopharyngeal cancer. It is for patients with advanced but not metastatic disease who are in good overall health.
This trial compares two treatment plans for newly diagnosed, operable nasopharyngeal cancer: adding surgery plus targeted chemoradiation versus standard chemoradiation alone. It aims to see whether the surgery-based plan improves control of the cancer and related outcomes.
This trial tests whether switching to a different chemotherapy or going straight to radiation helps patients whose nasopharyngeal cancer did not shrink after two rounds of initial chemotherapy. It compares two approaches to see which is more effective for people whose cancer is stable or growing after induction chemotherapy.
This Phase 3 trial tests giving chemotherapy first, then either radiation alone or chemotherapy together with radiation. It aims to improve treatment control for people with newly diagnosed, advanced nasopharyngeal cancer.
Hear when a new Nasopharyngeal Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.